Clinical Trial Update: Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy [Phase 1, Phase 2]

View source ↗

Summary

The trial investigates whether vasodilator therapy with isosorbide mononitrate or diltiazem can mitigate vasotoxicity in patients with digestive system neoplasm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Neoplasms

Drugs mentioned

• Diltiazem (diltiazem)
• Isosorbide Mononitrate (isosorbide mononitrate)

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Digestive System Neoplasm | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING